Press Releases
Please, enter cell line, author or any other phrase or word you would like to search for.
PHI raises 4.8 million USD
Cell laboratory at Japanese University orders third HoloMonitor
One of the cell laboratories at Kyushu University in Japan has ordered two HoloMonitor® instruments to complement the instrument previously purchased by the laboratory. The university is one of the seven imperial universities which today form Japan’s prestigious national universities.
Nature publish HoloMonitor Research
Cells cultivated on nanowires, imaged by HoloMonitor Researchers at Lund University have used HoloMonitor® technology from Phase Holographic Imaging to investigate the behavior of cells when cultivated on nanowires. The findings were recently published in Scientific Reports – anonline journal published by Nature Publishing Group.
PHI and Boston Children’s Hospital enter evaluation agreement
PHI and Boston Children’s Hospital – a Harvard Medical School teaching hospital – have signed an agreement to evaluate PHI’s HoloMonitor®technology for applications in cell-based cancer research.
PHI and Boston Children’s Hospital enter evaluation agreement
Big Pharma company orders third HoloMonitor
HoloMonitor provide vital information to development of improved child cancer treatment
PHI achieves market acceptance goals
Prior to the company’s IPO in early 2014, three market acceptance goals were set out to be achieved by the end of 2015: 50 units in operation at customers and key opinion leaders, collaboration agreements with 8 key opinion leaders and the company’s main product HoloMonitor® M4 shall be manufactured in series production.
PHI invited to speak at world leading scientific event
Big Pharma embraces HoloMonitor technology from PHI
Upon completion of an extensive evaluation in early September one of the top pharmaceutical companies in the world has decided to acquire two HoloMonitor® instruments. The ordered configuration is an automated version of the HoloMonitor platform.